IRGRILHDGAYSLTLQGLGIH (TFA)
Product Specifications
UNSPSC Description
IRGRILHDGAYSLTLQGLGIH TFA is a multi-epitope class II rat HER2/neu peptide. IRGRILHDGAYSLTLQGLGIH TFA can be used for the research class II HER2-DC1 vaccine studies[1].
Target Antigen
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/irgrilhdgaysltlqglgih-tfa.html
Solubility
10 mM in DMSO
Smiles
CC[C@H](C)[C@H](N)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@@H](CC(O)=O)C(NCC(N[C@@H](C)C(N[C@H](C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(NCC(N[C@@H](CC(C)C)C(NCC(N[C@@H]([C@@H](C)CC)C(N[C@H](C(O)=O)CC1=CN=CN1)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC2=CC=C(C=C2)O)=O)=O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)=O)=O.O=C(C(F)(F)F)O.[x]
Molecular Weight
2290.62 (free acid)
References & Citations
[1]Kodumudi KN, et, al. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Front Immunol. 2019 Aug 14;10:1939.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P5743A/IRGRILHDGAYSLTLQGLGIH-TFA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P5743A/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
